Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Mycoses 2Leukemia 2Invasive Fungal Infections 2Pulmonary Aspergillosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neutropenia 1Neoplasms 1Leukemia, Myelomonocytic, Acute 1Invasive Pulmonary Aspergillosis 1Hematologic Neoplasms 1HIV Infections 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Aspergillosis 1Anastomotic Leak 1

Interventions

pegfilgrastim 30Filgrastim 29Cyclophosphamide 10pegylated granulocyte colony-stimulating factor 8Docetaxel 8Etoposide 7Cytarabine 7Ciprofloxacin 6Cefepime 6Vancomycin 5Leucovorin 5Fluorouracil 5eflapegrastim 4Granulocyte Colony-Stimulating Factor 4Doxorubicin 4Peripheral Blood Stem Cell Transplantation 3Mitoxantrone 3Methotrexate 3Levofloxacin 3Irinotecan 3Idarubicin 3Daunorubicin 3Cyclosporine 3Caspofungin 3Carboplatin 3Amikacin 3trifluridine tipiracil drug combination 2plerixafor 2liposomal amphotericin B 2Vincristine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neutropenia × Amphotericin B × Clear all
NCT00002277 2005-06-24

A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections

NIH AIDS Clinical Trials Information Service

Phase 3 Completed

Mycoses, Neoplasms, Neutropenia, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡